These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33864171)

  • 1. Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism.
    Ju H; Lee EJ; Lee M; Kwon KY
    Neurol Sci; 2021 Aug; 42(8):3435-3437. PubMed ID: 33864171
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism with newly diagnosed flare-up rheumatoid arthritis mimicking progressive supranuclear palsy.
    Lee KW; Chien CF; Wu MN; Lai CL; Liou LM
    Neurol India; 2020; 68(2):481-482. PubMed ID: 32415030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
    Kasahata N; Hagiwara M; Kato H; Nakamura A; Uchihara T
    J Alzheimers Dis; 2014; 39(3):471-6. PubMed ID: 24217279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
    Bhidayasiri R; Jitkritsadakul O; Boonrod N; Rerknimitr R
    Clin Neurol Neurosurg; 2014 Jan; 116():1-3. PubMed ID: 24388506
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing.
    Modreanu R; Özdemir G; Buhmann C; Hauptmann B
    J Neurol Sci; 2018 May; 388():139-140. PubMed ID: 29627008
    [No Abstract]   [Full Text] [Related]  

  • 8. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Mark MH; Sage JI; Walters AS; Duvoisin RC; Miller DC
    Mov Disord; 1995 Jul; 10(4):450-4. PubMed ID: 7565825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.
    Quattrone A; Morelli M; Williams DR; Vescio B; Arabia G; Nigro S; Nicoletti G; Salsone M; Novellino F; Nisticò R; Pucci F; Chiriaco C; Pugliese P; Bosco D; Caracciolo M
    Neurology; 2016 Sep; 87(12):1266-73. PubMed ID: 27558375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.
    Williams DR; Hadeed A; al-Din AS; Wreikat AL; Lees AJ
    Mov Disord; 2005 Oct; 20(10):1264-71. PubMed ID: 15986421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.
    Mostile G; Nicoletti A; Cicero CE; Cavallaro T; Bruno E; Dibilio V; Luca A; Sciacca G; Raciti L; Contrafatto D; Chiaramonte I; Zappia M
    Neurol Sci; 2016 Apr; 37(4):591-5. PubMed ID: 26820655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Challenges in the differential diagnoses of parkinsonism].
    Bech S; Haugbøl S; Winge K
    Ugeskr Laeger; 2017 Aug; 179(33):. PubMed ID: 28869013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
    Ishida C; Takahashi K; Kato-Motozaki Y; Tagami A; Komai K
    Intern Med; 2021 Feb; 60(3):367-372. PubMed ID: 32963152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
    Bergmann KJ; Salak VL
    Parkinsonism Relat Disord; 2008; 14(4):348-52. PubMed ID: 17825599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for fast automated assessment of the magnetic resonance parkinsonism index.
    Scheffler M; Maréchal B; Boto J; Lövblad KO; Vargas MI
    Neuroradiology; 2020 Jun; 62(6):747-751. PubMed ID: 32095870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.
    Ilgin N; Zubieta J; Reich SG; Dannals RF; Ravert HT; Frost JJ
    Neurology; 1999 Apr; 52(6):1221-6. PubMed ID: 10214747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.